These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 1352058)

  • 1. Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze.
    Wright IK; Heaton M; Upton N; Marsden CA
    Psychopharmacology (Berl); 1992; 107(2-3):405-14. PubMed ID: 1352058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models.
    Artaiz I; Romero G; Zazpe A; Monge A; Calderó JM; Roca J; Lasheras B; Del Río J
    Psychopharmacology (Berl); 1995 Jan; 117(2):137-48. PubMed ID: 7753959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced anxiolytic effect of zacopride enantiomers in diazepam-withdrawn rats.
    File SE; Andrews N
    Eur J Pharmacol; 1993 Jun; 237(1):127-30. PubMed ID: 8102974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze.
    Wright IK; Upton N; Marsden CA
    Psychopharmacology (Berl); 1992; 109(3):338-46. PubMed ID: 1285416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of benzodiazepine withdrawal anxiety in the rat by serotonin antagonists.
    Begg DP; Hallam KT; Norman TR
    Behav Brain Res; 2005 Jun; 161(2):286-90. PubMed ID: 15922055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early life protein malnutrition changes exploration of the elevated plus-maze and reactivity to anxiolytics.
    Almeida SS; de Oliveira LM; Graeff FG
    Psychopharmacology (Berl); 1991; 103(4):513-8. PubMed ID: 1676529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of GABA and serotonin in the anxiolytic action of diazepam and serotonergic anxiolytics.
    López-Rubalcava C; Saldívar A; Fernández-Guasti A
    Pharmacol Biochem Behav; 1992 Oct; 43(2):433-40. PubMed ID: 1359576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonergic mechanisms involved in the exploratory behaviour of mice in a fully automated two-compartment black and white text box.
    Sánchez C
    Pharmacol Toxicol; 1995 Jul; 77(1):71-8. PubMed ID: 8532615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparison of benzodiazepine derivatives and serotonergic agonists and antagonists in two animal models of anxiety.
    Stefański R; Pałejko W; Kostowski W; Płaźnik A
    Neuropharmacology; 1992 Dec; 31(12):1251-8. PubMed ID: 1470301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are there changes in sensitivity to 5-HT3 receptor ligands following chronic diazepam treatment?
    Andrews N; File SE
    Psychopharmacology (Berl); 1992; 108(3):333-7. PubMed ID: 1523283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are 5-HT2 antagonists endowed with anxiolytic properties in rodents?
    Stutzmann JM; Eon B; Darche F; Lucas M; Rataud J; Piot O; Blanchard JC; Laduron PM
    Neurosci Lett; 1991 Jul; 128(1):4-8. PubMed ID: 1681477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha 2-adrenoceptor antagonists potentiate the anticonflict and the rotarod impairing effects of benzodiazepines.
    Söderpalm B; Engel JA
    J Neural Transm; 1989; 76(3):191-204. PubMed ID: 2567344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam.
    Costall B; Jones BJ; Kelly ME; Naylor RJ; Oakley NR; Onaivi ES; Tyers MB
    Pharmacol Biochem Behav; 1989 Dec; 34(4):769-78. PubMed ID: 2576143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alpha-2 antagonists idazoxan and rauwolscine but not yohimbine or piperoxan are anxiolytic in the Vogel lick-shock conflict paradigm following intravenous administration.
    La Marca S; Dunn RW
    Life Sci; 1994; 54(10):PL179-84. PubMed ID: 7906377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A re-evaluation of the role of alpha 2-adrenoceptors in the anxiogenic effects of yohimbine, using the selective antagonist delequamine in the rat.
    Redfern WS; Williams A
    Br J Pharmacol; 1995 Oct; 116(3):2081-9. PubMed ID: 8640349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance to acute anxiolysis but no withdrawal anxiogenesis in mice treated chronically with 5-HT1A receptor antagonist, WAY 100635.
    Cao BJ; Rodgers RJ
    Neurosci Biobehav Rev; 1998; 23(2):247-57. PubMed ID: 9884117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural profiles in the mouse defence test battery suggest anxiolytic potential of 5-HT(1A) receptor antagonists.
    Griebel G; Rodgers RJ; Perrault G; Sanger DJ
    Psychopharmacology (Berl); 1999 May; 144(2):121-30. PubMed ID: 10394992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabotropic glutamate receptor 4 novel agonist LSP1-2111 with anxiolytic, but not antidepressant-like activity, mediated by serotonergic and GABAergic systems.
    Wierońska JM; Stachowicz K; Pałucha-Poniewiera A; Acher F; Brański P; Pilc A
    Neuropharmacology; 2010 Dec; 59(7-8):627-34. PubMed ID: 20713068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiolytic-like effect of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (60) in experimental mouse models of anxiety.
    Bhatt S; Mahesh R; Devadoss T; Jindal A
    Indian J Exp Biol; 2013 Jul; 51(7):510-4. PubMed ID: 23898549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of DN-2327, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in an elevated plus-maze.
    Wada T; Fukuda N
    Psychopharmacology (Berl); 1991; 104(4):444-50. PubMed ID: 1685794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.